Nektar Therapeutics (NKTR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:42AM EDT. Market open.
| Previous Close | 1.3500 |
| Open | 1.3200 |
| Bid | 1.3000 x 1400 |
| Ask | 1.3600 x 1200 |
| Day's Range | 1.3000 - 1.3600 |
| 52 Week Range | 0.4100 - 1.7500 |
| Volume | |
| Avg. Volume | 2,378,258 |
| Market Cap | 246.048M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
The placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar's (NKTR) rezpeg in patients with severe to very severe alopecia areata.
- Zacks
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
Nektar (NKTR) reports a wider-than-expected loss in the fourth quarter of 2023 while revenue beat estimates.
© 2024 Yahoo. All rights reserved.